The Intelis platform monitors patient activity 24/7, which means physicians can make treatment adjustments as needed.
Neurostimulation through percutaneous electrical nerve field stimulation was shown to durably reduce pain in children.
Transcutaneous supraorbital neurostimulation provides an effective prophylactic treatment for patients with chronic migraine.
Vagus nerve stimulation inhibits cytokine production and reduces inflammation, and may be effective for a subset of RA patients.
Sixty and 35 percent of patients achieved a 30 and 50% reduction, respectively, in headache days and/or pain intensity.
Spinal cord stimulation, neurotechnology, acupuncture, neurostimulation: all effective in treating migraine, headaches.
Clinical Pain Advisor Articles
- Two Screening Tools May Accurately Predict Transition From Acute to Chronic Low Back Pain
- Tools to Address the Opioid Crisis
- Methamphetamine Use on the Rise in Patients With Opioid Use Disorder
- Operant Learning May Provide More Benefits Than Energy Conservation in Fibromyalgia
- Half of the Responders to Our Poll Agree With the Approval of Dsuvia: We Want to Hear From You
- The Unintended Consequences of the CDC Opioid Guideline According to Pain Management Specialists
- Initial Consultation for Neck Pain May Reduce Opioid Consumption, Healthcare Utilization
- FDA-Approved Test Provides Pharmacogenetic Reports Directly to Consumers
- Set of Interventions May Effectively Reduce Opioid Overprescribing
- Cannabinoid-Associated Analgesia May Be Mediated Through Modulation of Affective Processes
- FDA Panel Votes in Favor of Abuse-Deterrent Oxycodone Reformulation
- FDA Proposes New Restrictions on Sale of Electronic Nicotine Delivery Systems
- Central Sensitization in Greater Trochanteric Pain Syndrome
- Pain Acceptance May Reduce Headache-Related Disability in Migraine
- FDA Issues Safety Alert Regarding Intrathecal Delivery of Pain Meds